Review article in high impact journal outlines the evidence that neurodegenerative diseases –including Parkinson’s, Alzheimer’s, ALS and Huntington’s – can be addressed by boosting mitophagy, the quality control system cells use to remove...
Drug discovery and novel disease treatments are major areas of research, with constant innovation. Delivering these drugs and treatments completely and precisely has been a major hurdle that researchers continue to grapple with. Now, a research team at the Ottawa...
Eli Lilly and Co. (LLY.N), a major global pharmaceutical company, has formed a research partnership with Genetic Leap, a startup that uses artificial intelligence (AI) and machine learning for drug discovery. The deal is valued at $409 million and focuses on...
Venture capital giant Flagship Pioneering plans to support the creation and development of about 25 new startups in life sciences or “human health,” sustainability, and artificial intelligence over the next three to five years with a combined $3.6 billion in new...
“Revolutionizing Healthcare Horizons: Delving Deep into Advanced Drug Delivery Systems (ADDS) and Forecasting an Explosive $359.1 Billion Market Growth by 2028, BCC Research Study” Demand for effective solutions has never been so urgent to prevent global...
